Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study

• Status: Completed
• Trial end date: 2006-04-01

Summary

The purpose of this study is to determine whether mesalamine is effective in the treatment of uncomplicated diverticular disease by reducing the pain.

• Phase: Phase 2

Details

• Lead Sponsor: Dr. Falk Pharma GmbH
• Treatments: Mesalamine